Effect of Rosiglitazone and Insulin Combination Therapy on Inflammation Parameters and Adipocytokine Levels in Patients with Type 1 DM

Table 4

Complications observed in the groups.

Complication	Group 1; Insulin + Ros	Group 2; Insulin
Minor hypoglycemia events experienced per patient	5.35	4.61	0.437
Major hypoglycemia events	2	—	NA
Acute metabolic complication DK/DKA/NKNAHS	—	2	NA
Mean weight gain (kg)	2.58 ± 3.10	1.47 ± 1.53	0.142

Ros: rosiglitazone; DK: diabetic ketosis; DKA: diabetic ketoacidosis; NKNAHS: nonketotic nonacidotic hyperosmolar syndrome; NA: not available.